Community Pharmacies
Debate between Rachel Gilmour and Gagan Mohindra(1 week, 5 days ago)
Westminster HallRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Rachel Gilmour (Tiverton and Minehead) (LD)
I beg to move,
That this House has considered the future of community pharmacies.
It is always a pleasure to see the Minister in his place. I know how committed he is to his brief, and I am grateful for the conversations we have had on a number of important issues. The timing of this debate could hardly be better, coming as it does in the wake of the Government’s announcement just before the weekend. That announcement provides the perfect context within which to couch my remarks. I would like to believe that I have developed a reputation for constructive criticism, and I hope to offer a fair-minded but frank scrutiny of the Government’s plans for community pharmacies. There are positive moves, which I welcome, but there is also considerably further to go.
It is clear that the national picture for community pharmacies is one of an incredibly fragile system, and I am sure that much reference will be made this morning to the damning headline statistic that since 2016, over 1,000 pharmacies have been lost across England. Funding was cut that same year and remained flat in cash terms until 2024, even as the volume of NHS pharmaceutical care and the cost of providing it surged.
Mr Gagan Mohindra (South West Hertfordshire) (Con)
I congratulate the hon. Member on securing the debate. When I met the Minister in April, we were going through the consultation on the pharmacy contract, but we are yet to hear any announcement. Does the hon. Member agree that the pharmacies we all rely on need certainty about when their contract negotiations and the associated funding will be completed?
Rachel Gilmour
The hon. Member makes a good point, which I shall return to in due course.
The community pharmacy network has had to absorb real-terms cuts of 30% in Government funding. For most community pharmacies, NHS funding accounts for 90% to 95% of their annual income. That is simply not a sustainable business model; it is a slow strangulation. The Government’s own independent economic analysis, published as recently as March this year, found the gap to be £2 billion a year. More recently still, the Government have admitted that pharmacies in England were funded £800 million less in real terms in 2025-26 than they were a decade ago. It is important to be clear that those are the Government’s own figures.
Against that backdrop, I welcome the funding settlement for 2026-27.